NCT03860987 2026-05-22Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate CancerNational Institutes of Health Clinical Center (CC)Phase 2 Completed12 enrolled